Grimer R J, Carter S R, Spooner D, Sneath R S
The Royal Orthopaedic Hospital Oncology Service Birmingham UK.
Sarcoma. 2001;5(2):89-94. doi: 10.1155/S1357714X01000172.
In 1993 we became aware of a worrying increase in apparent errors in the histopathological diagnosis of musculoskeletal tumours in our Unit. As a result all cases seen over the past 8 years were reviewed by an independent panel. Of the 1996 cases reviewed there was an error in 87. In 54 cases (2.7%) this had led to some significant change in the active management of the patient. The main areas where errors arose were in those very cases where clinical and radiological features were not helpful in confirming or refuting the diagnosis. The incidence of errors rose with the passage of time, possibly related to a deterioration in the pathologist's health. The error rate in diagnosing bone tumours in previously published series ranges from 9 to 40%. To ensure as accurate a rate of diagnosis as possible multidisciplinary working and regular audit are essential.
1993年,我们注意到本单位肌肉骨骼肿瘤组织病理学诊断中明显错误的数量令人担忧地增加。因此,一个独立小组对过去8年中诊治的所有病例进行了复查。在复查的1996例病例中,有87例存在错误。其中54例(2.7%)导致了患者积极治疗方面的一些重大改变。出现错误的主要领域正是那些临床和放射学特征无助于确诊或排除诊断的病例。错误发生率随着时间的推移而上升,这可能与病理学家健康状况的恶化有关。先前发表的系列研究中骨肿瘤的诊断错误率在9%至40%之间。为确保尽可能准确的诊断率,多学科协作和定期审核至关重要。